Cigna uses OpenAI AI to support patients with complex illnesses
Cigna and OpenAI have formed a partnership to embed AI-powered assistance for individuals managing complex illnesses, with cancer treatment as the initial focus. The initiative uses OpenAI’s Frontier model to enhance clinical operations, delivering customized support to oncology nurses and case managers through Accredo Specialty Pharmacy and Cigna Healthcare.
The AI platform will analyze clinical records, pharmacy data, behavioral insights, and benefits information to predict patient needs and improve care coordination. Between medical appointments, patients will receive personalized outreach to help them address treatment-related side effects, new symptoms, and logistical hurdles. Data from patient interactions, such as questions asked, reported side effects, and preferences for care navigation, will continuously refine support strategies and optimize clinical processes.
OpenAI’s Frontier system, launched in February, allows businesses to deploy AI agents capable of maintaining conversational context, onboarding users, learning through interaction, and operating within defined permissions. For Cigna, this means the AI can function as a persistent support resource, filling gaps in care when patients encounter questions or complications outside scheduled visits.
This development follows Cigna’s ongoing AI investments, including the Pharmacy Forward initiative, an Accredo program funded with $100 million through 2028 to enhance medication adherence. Earlier this year, the company expanded its AI-driven care management tools, which have already lowered preventable hospital admissions by 42% among participating patients. The new collaboration aims to extend assistance to 20% more individuals with chronic or complex conditions, including heart disease, kidney disease, and behavioral health disorders.
Dr. Amy Flaster, chief medical officer of The Cigna Group, explained that complex diagnoses create significant emotional and practical challenges for patients. The AI integration will improve access to specialized clinicians and resources, addressing both functional and emotional concerns. “This is how we can begin to realize the promise of AI to unlock better health outcomes: identifying issues earlier, offering support between doctors’ visits, and making complex care feel less overwhelming.”
The Frontier model will also generate insights that feed back into clinical workflows, creating a continuous improvement cycle. For instance, if cancer patients repeatedly report difficulties with a specific side effect, the system can alert nurses or pharmacists to take preventive action. Over time, this could lower hospital readmissions by addressing issues before they worsen.
